Nutriband Inc. Common Stock (NTRB) Stock Price

NTRBStock

$6.22−19.22%52W

Market Cap$75.61M

P/E—

PEG Ratio—

Div yield—

Beta2.15

NTRB Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)43.30%

Price vs S&P 500 (4W)-18.62%

VGM Score38.01

Book Value / Share (Quarterly)$0.44

P/TBV (Annual)8.81x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-0.69%

Cash Flow / Share (Quarterly)$-0.30

Price vs S&P 500 (YTD)25.08%

Gross Margin (TTM)33.14%

Net Profit Margin (TTM)-430.43%

EPS (TTM)$-0.58

10-Day Avg Trading Volume0.04M

EPS Excl Extra (TTM)$-0.58

Revenue Growth (5Y)16.63%

EPS (Annual)$-0.71

ROI (Annual)-120.24%

Gross Margin (Annual)27.81%

Net Profit Margin (5Y Avg)-361.39%

Cash / Share (Quarterly)$0.28

Revenue Growth QoQ (YoY)-29.71%

ROA (Last FY)-109.03%

Revenue Growth TTM (YoY)-37.25%

EBITD / Share (TTM)$-0.57

ROE (5Y Avg)-95.17%

Operating Margin (TTM)-435.58%

Cash Flow / Share (Annual)$-0.42

P/B Ratio14.19x

P/B Ratio (Quarterly)6.50x

Net Income / Employee (Annual)$-633,000

EV / Revenue (TTM)44.72x

Net Interest Coverage (TTM)-92.02x

ROA (TTM)-95.54%

EPS Incl Extra (Annual)$-0.71

Current Ratio (Annual)6.36x

Quick Ratio (Quarterly)3.80x

3-Month Avg Trading Volume0.05M

52-Week Price Return-19.22%

Revenue / Employee (TTM)$124,400

Tangible BV / Share (Quarterly)$0.42

P/S Ratio (Annual)37.12x

Asset Turnover (Annual)0.27x

52-Week High$9.19

Operating Margin (5Y Avg)-361.54%

EPS Excl Extra (Annual)$-0.71

Tangible BV CAGR (5Y)1.20%

26-Week Price Return53.20%

Quick Ratio (Annual)5.98x

13-Week Price Return100.00%

Total Debt / Equity (Annual)0.02x

Current Ratio (Quarterly)4.21x

Enterprise Value$72.34M

Revenue / Share Growth (5Y)4.53%

Asset Turnover (TTM)0.22x

Book Value / Share Growth (5Y)-10.82%

Revenue / Employee (Annual)$156,700

Inventory Turnover (Annual)8.91x

Pretax Margin (Annual)-404.08%

Cash / Share (Annual)$0.38

3-Month Return Std Dev113.83%

Gross Margin (5Y Avg)35.09%

Net Income / Employee (TTM)$-535,600

ROE (Last FY)-123.21%

Net Interest Coverage (Annual)-89.73x

EPS Basic Excl Extra (Annual)$-0.71

Receivables Turnover (TTM)17.55x

Total Debt / Equity (Quarterly)0.03x

EPS Incl Extra (TTM)$-0.58

Receivables Turnover (Annual)21.19x

ROI (TTM)-106.33%

P/S Ratio (TTM)46.74x

Pretax Margin (5Y Avg)-361.39%

Revenue / Share (Annual)$0.17

Tangible BV / Share (Annual)$0.53

Forward P/E3.96x

Price vs S&P 500 (52W)-34.75%

Year-to-Date Return37.00%

5-Day Price Return6.32%

EPS Normalized (Annual)$-0.71

ROA (5Y Avg)-83.64%

Net Profit Margin (Annual)-404.08%

Month-to-Date Return-17.29%

Cash Flow / Share (TTM)$-0.55

EBITD / Share (Annual)$-0.70

Operating Margin (Annual)-408.41%

LT Debt / Equity (Annual)0.01x

ROI (5Y Avg)-92.88%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.58

P/TBV (Quarterly)6.72x

P/B Ratio (Annual)8.55x

Inventory Turnover (TTM)7.01x

Pretax Margin (TTM)-430.43%

Book Value / Share (Annual)$0.55

Price vs S&P 500 (13W)97.31%

Beta2.15x

Revenue / Share (TTM)$0.13

ROE (TTM)-109.02%

52-Week Low$2.80

vGradeF

gGradeD

mGradeB

vgmGradeD

NTRB Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q4 2025	Apr 29, 2026	-$1.89	-$0.04	+97.88%(+$1.85)
Q3 2025	Dec 11, 2025	-$2.13	-$0.32	+84.98%(+$1.81)
Q2 2025	Sep 9, 2025	-$0.17	-$2.12	-1147.06%(-$1.95)
Q1 2025	May 30, 2025	-$0.16	-$0.12	+25.00%(+$0.04)

NTRB Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.14

Industry Peers — Orthopedic & Prosthetic Devices(31)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
NTRBNutriband Inc. Common Stock	F	D	B	46.7x	16.6%	33.1%	-435.6%	$6.22
ISRGIntuitive Surgical Inc.	D	B	B	13.7x	18.2%	66.7%	31.3%	$426.70
EWEdwards Lifesciences Corp	D	C	B	7.7x	6.7%	77.8%	18.2%	$86.60
STESTERIS plc	C	C	B	3.6x	13.8%	44.4%	18.9%	$222.66
ZBHZimmer Biomet Holdings, Inc.	B	C	B	2.1x	3.2%	69.9%	14.2%	$94.98
SNNSmith & Nephew plc	B	C	C	1.9x	6.2%	68.2%	12.9%	$29.06
ALGNAlign Technology Inc	B	D	C	2.5x	10.3%	69.0%	13.2%	$147.31
MSAMine Safety Incorporated	C	C	B	3.5x	6.8%	47.6%	21.2%	$179.05
ESTAEstablishment Labs Holdings Inc.	F	A	C	7.2x	20.0%	70.5%	-7.6%	$59.18
ENOVEnovis Corporation	B	D	C	0.5x	-6.0%	61.4%	-45.1%	$19.59
CDRECadre Holdings, Inc.	B	C	C	1.6x	8.6%	41.8%	10.1%	$26.38
AVRAnteris Technologies Global Corp. Common Stock	D	C	C	263.0x	—	75.0%	-4738.4%	$6.05
SMTISanara MedTech Inc. Common Stock	D	C	B	2.8x	45.9%	93.0%	7.7%	$33.16
INGNInogen Inc	B	D	C	0.5x	2.5%	44.5%	-8.7%	$6.25
ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares	F	D	C	6.3x	5.0%	29.2%	2.9%	$2.08
LAKELakeland Industries Inc	B	D	D	0.5x	3.9%	32.6%	-4.1%	$9.09
CNXUConexeu Sciences Inc. Common Stock	—	—	F	—	—	—	—	$3.06
SPAISafe Pro Group Inc. Common Stock	F	A	D	23.3x	—	62.2%	-513.8%	$3.30
APTAlpha Pro Tech, Ltd.	A	D	B	0.9x	-10.4%	37.5%	7.5%	$5.55
COCHEnvoy Medical, Inc. Class A Common Stock	F	F	C	249.8x	—	-385.5%	-11411.1%	$0.67
MYOMyomo Inc.	B	B	B	1.1x	40.1%	68.3%	-27.1%	$1.20
MLSSMilestone Scientific, Inc. Common Stock	D	C	C	3.1x	10.5%	70.2%	-43.6%	$0.33
LFWDLifeward Ltd. Ordinary Shares	A	C	C	1.1x	38.1%	32.9%	-125.5%	$6.00
CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares	—	D	F	196.5x	—	-0.4%	-9352.8%	$1.90
RGNTRegentis Biomaterials Ltd.	—	—	D	—	—	—	—	$1.49
CLGNCollPlant Biotechnologies Ltd Ordinary Shares	D	F	C	17.6x	-17.3%	-147.6%	-3329.1%	$3.63
BBLGBone Biologics Corp Common Stock	—	—	F	—	—	—	—	$0.40
FEEDENvue Medical, Inc. Common Stock	—	F	F	0.2x	—	-26.1%	-1362.7%	$0.37
AVNSAvanos Medical, Inc.	B	D	B	1.6x	-0.4%	50.0%	-8.8%	$0.00
BBLGWBone Biologics Corp Warrants	—	—	D	—	—	—	—	$7.70
COCHWEnvoy Medical, Inc Warrant	—	—	D	—	—	—	—	$0.04
NTRBWNutriband Inc. Warrant	—	—	D	—	—	—	—	$0.55

About Nutriband Inc. Common Stock

Nutriband Inc develops transdermal pharmaceutical products designed to prevent drug abuse and diversion. The company's proprietary AVERSA technology incorporates aversive agents into pharmaceutical formulations to reduce the risk of opioid abuse and misuse. Revenue is generated through the sale of consumer transdermal and coated pharmaceutical products.